Shares of Cepheid hit a 52-week high of $20.29 on Tuesday before closing at $20.17. The stock led all gainers in the BCW Index for the three-week period ended Tuesday, up 19.4 percent (BioCommerce Week did not publish the past two weeks and the last Index ran on Aug. 15). Cepheid signed an anthrax test agreement with the US Postal Service in mid-August worth a potential $200 million to the firm (see Briefs).
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.